SMS Reminders and Treatment Compliance and Efficacy in Patients With FGIDs

Shanghai Jiao Tong University

Status: Unknown

Conditions: Functional Gastrointestinal Disorders; Patient Compliance

Treatments: Behavioral: SMS follow-up

Study type: Interventional

Funder types: Other

Identifiers

NCT04052750

RJYYXHNK-004

Details and patient eligibility

About

The effect of SMS follow-up on drug compliance and efficacy in patients with FGIDs has not been reported in the literature. We, therefore, conducted a prospective randomized controlled trial to investigate whether SMS follow-up could improve treatment adherence in patients with FGIDs, which in turn would help symptom relief and improve treatment outcomes.

Full description

The irritable bowel syndrome (IBS) and other functional gastrointestinal disorders (FGIDs) are common and pose significant burdens to patients. Although regular medications have substantial benefits for disease remission, many patients do not follow the recommendations of standard medication regimens given by physicians at the time of the visit, so how to improve patient compliance becomes even more important. Many factors can affect drug compliance. Forgetting seems to be one of the important reasons for poor compliance. In order to solve this problem, many studies such as drug charts/calendars, mini kits, etc. have been conducted in previous studies. At present, with the popularization of mobile phones, SMS-based interventions are gradually being applied to various medical environments. Compared with the phone, SMS consumes less time and can be easily integrated into the patient's daily life. Therefore, short messages may be more suitable for follow-up of patients outside hospital.

Enrollment: 176 estimated patients

Sex: All

Ages: 18 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with newly diagnosed FGIDs according to Rome-IV
• Aged 18-70 years
• With no obvious organic abnormalities

Exclusion criteria

• With organic gastrointestinal diseases
• With psychiatric diseases or are taking psychotropic agents
• With severe cardiopulmonary or other organ diseases
• Pregnant women

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

176 participants in 2 patient groups

The control group

No Intervention group

Description:

Patients in this group only received medications without daily text message reminder

The intervention group

Experimental group

Description:

Patients in this group received a daily short message service (SMS) reminder when medications were prescribed

Treatment:

Behavioral: SMS follow-up